- What the BCTXP Exam Actually Tests
- Domain 1: Solid Organ Transplantation (19%)
- Domain 2: Therapeutics and Patient Management (63%)
- Domain 3: Professional Practice (18%)
- Exam Format, Question Types, and Timing
- Scoring and the Passing Standard
- Eligibility Pathways Tied to the Domains
- Allocating Study Time by Domain Weight
- Who Hires Pharmacists With This Credential
- FAQ
- The BCTXP outline has exactly three domains: Solid Organ Transplantation (19%), Therapeutics and Patient Management (63%), and Professional Practice (18%).
- Therapeutics and Patient Management alone is worth almost two-thirds of the 125 scored questions.
- The exam is 150 questions (125 scored, 25 unscored pretest) over 3 hours 45 minutes, closed-book, forward-only navigation.
- Passing requires a scaled score of 500 on a 200-800 scale; specifications in effect are dated January 2024.
What the BCTXP Exam Actually Tests
The Board-Certified Transplant Pharmacist (BCTXP) examination administered by the Board of Pharmacy Specialties (BPS) is organized around three content domains, not a generic pharmacotherapy checklist. If you want to know exactly what to study - and, just as important, what to deprioritize - the domain outline is the single most useful document you can read before opening a review book. This guide breaks down all three areas using the current specifications, effective January 2024, and connects each one to the exam's structure so you can build a realistic prep timeline instead of guessing.
For a broader walkthrough of preparation strategy, see the companion BCTXP Study Guide 2026: How to Pass on Your First Attempt. If you're still deciding whether to pursue the credential, the Is the BCTXP Certification Worth It? Complete ROI Analysis 2026 article covers that decision separately.
Domain 1: Solid Organ Transplantation (19%)
This domain covers the foundational, non-drug-specific knowledge a transplant pharmacist needs before therapeutics even enters the picture: transplant candidacy evaluation, organ allocation concepts, donor-recipient matching considerations, immunologic principles underlying rejection, and the perioperative course across solid organ types.
Domain 1: Solid Organ Transplantation
Candidates must understand the clinical and systems-level context surrounding a transplant episode - not just the medications used during it.
- Pretransplant evaluation and candidacy criteria across organ types
- Immunologic basis of rejection and sensitization
- Perioperative and early post-transplant clinical course
- Organ-specific considerations that differentiate kidney, liver, heart, lung, and pancreas transplantation
Because this domain is the smallest at 19% of the exam, it is tempting to skim it. Don't. Questions here set up the clinical scenarios that carry into Domain 2 questions, so weak foundational knowledge compounds into missed points elsewhere on the test.
Domain 2: Therapeutics and Patient Management (63%)
This is the domain that decides most outcomes. At 63% of the total exam, Therapeutics and Patient Management is nearly two-thirds of the scored content, and BPS further breaks it into three named components: Treatment Planning (19% of the whole exam), Therapeutic Implementation (23%), and Treatment Outcomes and Monitoring (21%). Notice that no single component within this domain is small - each is a meaningful share on its own, comparable to the entire Professional Practice domain.
Treatment Planning - 19% of the total exam
Selecting and individualizing immunosuppressive and adjunctive regimens based on organ type, immunologic risk, and patient-specific factors.
- Induction and maintenance immunosuppression selection
- Regimen individualization for comorbidities, drug interactions, and prior sensitization
- Infection and malignancy prophylaxis planning
Therapeutic Implementation - 23% of the total exam
Carrying out and adjusting the treatment plan in real clinical situations, including dosing, drug interaction management, and acute complication response.
- Dose adjustments for renal/hepatic function, drug levels, and pharmacogenomics where relevant
- Managing acute rejection episodes and infectious complications
- Coordinating transitions of care across inpatient and outpatient settings
Treatment Outcomes and Monitoring - 21% of the total exam
Evaluating whether therapy is working and adjusting course based on labs, trough levels, biopsy results, and adverse effect surveillance.
- Interpreting immunosuppressant trough levels and pharmacokinetic monitoring
- Recognizing and managing drug-related toxicities and long-term complications
- Longitudinal monitoring strategies for graft function and adherence
Key Takeaway
Treat Therapeutics and Patient Management as three sub-exams inside the main exam. Study Treatment Planning, Therapeutic Implementation, and Treatment Outcomes and Monitoring as distinct blocks rather than one undifferentiated "therapeutics" pile.
Domain 3: Professional Practice (18%)
The final domain covers the non-clinical competencies expected of a board-certified transplant pharmacist: practice management, interprofessional collaboration, quality and safety processes, education, and the regulatory/administrative context in which transplant pharmacy operates.
Domain 3: Professional Practice
Candidates should be comfortable with the operational and collaborative side of transplant pharmacy practice, not only bedside therapeutics.
- Interprofessional communication within transplant teams
- Medication safety, quality improvement, and practice-based research concepts
- Patient and caregiver education strategies
- Regulatory and documentation responsibilities specific to transplant programs
At 18%, Professional Practice is close in size to Domain 1 and should receive proportional - not minimal - attention. Many candidates who focus exclusively on drug therapy find they underperform on this domain simply because they never reviewed it directly.
Exam Format, Question Types, and Timing
Understanding domain weighting only helps if you also understand how questions are delivered. The BCTXP exam is a computer-based test administered through Pearson VUE, consisting of 150 total questions - 125 scored and 25 unscored pretest items mixed in without identification - across 3 hours and 45 minutes, which includes the introduction and tutorial.
- Predominantly single-answer multiple-choice, with some multiple-response and image-supported items permitted by BPS
- Closed-book with forward-only navigation - you cannot skip a question or return to one you've already submitted
- An on-screen scientific calculator is provided
- One proctor-approved optional 10-minute break is available, but it uses examination time
- Remote testing exists as an exception requiring advance BPS approval, limited to eligible candidates in the United States, Australia, and Canada
The forward-only navigation rule has real strategic implications: you cannot mark a Domain 2 question for later review and come back after finishing Domain 3-style items, because BPS does not present questions in labeled domain blocks and does not allow backtracking at all. For a deeper breakdown of what exam day feels like, see How Hard Is the BCTXP Exam? Complete Difficulty Guide 2026.
Scoring and the Passing Standard
BCTXP results are reported as a scaled score on a 200-800 scale, with 500 required to pass. Because the domains are unevenly weighted, a candidate's overall scaled score is influenced far more by performance on Therapeutics and Patient Management questions than by any other single domain. A detailed explanation of how this scale translates into practical study targets is covered in BCTXP Passing Score 2026: Exactly What You Need to Pass.
| Domain | Weight | Approx. Scored Questions (of 125) |
|---|---|---|
| Solid Organ Transplantation | 19% | ~24 |
| Therapeutics and Patient Management | 63% | ~79 |
| - Treatment Planning | 19% | ~24 |
| - Therapeutic Implementation | 23% | ~29 |
| - Treatment Outcomes and Monitoring | 21% | ~26 |
| Professional Practice | 18% | ~23 |
Official 2025 certification results reported a 48.8% overall pass rate (20 passes among 41 attempts) and 46.4% for first-time candidates (13 passes among 28 attempts). Those numbers underline why domain-by-domain preparation, rather than broad general review, matters. For the full data breakdown, read BCTXP Pass Rate 2026: What the Data Shows.
Eligibility Pathways Tied to the Domains
Before you can sit for the exam covering these three domains, BPS requires an ACPE-accredited pharmacy degree (or qualifying international equivalent), active pharmacist licensure, and one of the following completed within the preceding seven years:
- Four years of postlicensure transplant practice, with at least 50% of time spent in the examination outline's content areas
- An eligible PGY1 residency plus two years of qualifying transplant practice
- An eligible PGY2 solid-organ-transplantation pharmacy residency
Practice-based pathways require employer attestation confirming the transplant-focused scope of your role. Given that "at least 50% of time in the examination outline" language, your day-to-day exposure to Domains 1, 2, and 3 isn't just background - it's literally part of how BPS verifies eligibility. Full pathway details are covered in BCTXP Requirements 2026: Eligibility, Prerequisites & How to Qualify.
Once eligible, the initial examination fee is $600, with eligible retakes at $300. Continuous testing uses a 90-day authorization-to-test window, and the retake policy allows three total attempts with a 90-day wait between attempts (and 90 days to schedule/complete once that wait ends). A third failure requires a 12-month wait and a new $600 application. See BCTXP Certification Cost 2026: Complete Pricing Breakdown and BCTXP Exam Dates 2026: Testing Windows, Deadlines & Scheduling for scheduling mechanics.
Allocating Study Time by Domain Weight
Rather than a generic weekly template, the most effective way to plan BCTXP prep is to size each study block to its domain weight, then subdivide Therapeutics and Patient Management into its three named components. A candidate with roughly eight weeks before their testing window might structure time like this:
Domain 1: Solid Organ Transplantation
- Review candidacy criteria and allocation concepts by organ type
- Build a rejection-immunology reference sheet
Treatment Planning + Therapeutic Implementation
- Drill induction/maintenance regimen selection scenarios
- Practice dose-adjustment problems tied to renal/hepatic function and drug levels
Treatment Outcomes and Monitoring
- Practice trough-level interpretation and toxicity recognition cases
- Review long-term complication surveillance protocols
Domain 3 + full mixed review
- Study interprofessional and quality/safety topics
- Run timed, mixed-domain practice sets that mimic forward-only navigation
Practicing under forward-only, no-backtrack conditions on our practice test platform before exam day helps you get comfortable committing to an answer permanently, which is a very different skill than reviewing flashcards. A condensed reference you can revisit the week of the test is available in the BCTXP Cheat Sheet 2026: One-Page Review of Must-Know Facts.
Who Hires Pharmacists With This Credential
The domains tested reflect the actual scope of transplant pharmacy practice: transplant centers, academic medical centers with solid organ programs, and health systems building out dedicated transplant pharmacy services typically look for candidates who can demonstrate competency across all three areas - not just drug therapy. Employers often view the credential as validation that a pharmacist can manage the full arc of care described in Domains 1 through 3, from pretransplant evaluation through long-term monitoring and interprofessional coordination. For more on career paths and hiring patterns, see BCTXP Jobs and BCTXP Salary Guide 2026: Complete Earnings Analysis.
If you're brand new to the credential itself and want the basics before diving into domain detail, start with What Is BCTXP? or explore more practice questions on the main BCTXP practice test site.
FAQ
Most candidates start with Domain 1 (Solid Organ Transplantation) because it establishes the clinical context used throughout Domain 2 questions, then move into Treatment Planning, Therapeutic Implementation, and Treatment Outcomes and Monitoring in sequence.
BPS's current outline assigns 63% of the exam to this domain because it reflects the core day-to-day clinical decision-making of transplant pharmacy practice, split into Treatment Planning (19%), Therapeutic Implementation (23%), and Treatment Outcomes and Monitoring (21%).
The percentages reflect the specifications currently in effect (dated January 2024, applicable to the 2025 administration onward per the BPS outline index). Always confirm against the current BPS outline before your specific testing window.
No. The BCTXP exam uses forward-only navigation, meaning you cannot skip questions or return to previously submitted answers, regardless of which domain the question falls under.
Weights apply to the 125 scored questions out of 150 total (the remaining 25 are unscored pretest items), so Domain 1 accounts for roughly 24 scored questions, Domain 2 roughly 79, and Domain 3 roughly 23 - though BPS does not guarantee exact counts per candidate form.